{"doi":"10.1161/circulationaha.124.071208","title":"Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial","abstract":"BACKGROUND: The MINT trial (Myocardial Ischemia and Transfusion) raised concern for harm from a restrictive versus liberal transfusion strategy in patients with acute myocardial infarction (MI) and anemia. Type 1 and type 2 MI are distinct pathophysiologic entities that may respond differently to blood transfusion. This analysis sought to determine whether the effects of transfusion varied among patients with a type 1 or a type 2 MI and anemia. The authors hypothesized that the liberal transfusion strategy would be of greater benefit in type 2 than in type 1 MI. METHODS: The authors compared rates of death or MI at 30 days in patients with type 1 (n=1460) and type 2 (n=1955) MI and anemia who were randomly allocated to a restrictive (threshold, 7–8 g/dL) or a liberal (threshold, 10 g/dL) transfusion strategy. RESULTS: The primary outcome of death or MI was observed in 16% of type 1 MI and 15.4% of type 2 MI patients. The rate of death or MI was higher in patients with type 1 MI randomized to a restrictive (18.2%) versus liberal (13.8%) transfusion strategy (relative risk [RR], 1.32 [95% CI, 1.04–1.67]) with no difference observed between the restrictive (15.8%) and liberal (15.1%) transfusion strategies in patients with type 2 MI (RR, 1.05 [95% CI, 0.85–1.29]). The test for a differential effect of transfusion strategy by MI type was not statistically significant ( P interaction = 0.16). CONCLUSIONS: The concern for harm with a restrictive transfusion strategy in patients with acute MI and anemia raised in the MINT primary outcome manuscript may be more apparent in patients with type 1 than type 2 MI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02981407.","journal":"Circulation","year":2024,"id":424767,"datarank":0.5891515827350434,"base_score":3.091042453358316,"endowment":3.091042453358316,"self_citation_contribution":0.4636563680037475,"citation_network_contribution":0.1254952147312959,"self_endowment_contribution":0.4636563680037475,"citer_contribution":0.1254952147312959,"corpus_percentile":null,"corpus_rank":null,"citation_count":21,"citer_count":12,"citers_with_citation_signal":3,"citers_with_endowment":3,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9541,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT02981407"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":228980,"name":"J. Dawn Abbott","orcid":"0000-0002-2560-0155","position":1,"is_corresponding":false},{"id":703370,"name":"Brandon M. Herbert","orcid":"0000-0003-3857-7422","position":2,"is_corresponding":false},{"id":263729,"name":"Marnie Bertolet","orcid":"0000-0002-5799-9033","position":3,"is_corresponding":false},{"id":227163,"name":"Bernard Chaitman","orcid":"0000-0002-9216-5317","position":4,"is_corresponding":false},{"id":314978,"name":"Harvey D. White","orcid":"0000-0001-7712-6750","position":5,"is_corresponding":false},{"id":947294,"name":"Andrew M. Goldsweig","orcid":"0000-0003-2952-7837","position":6,"is_corresponding":false},{"id":441255,"name":"Tamar S. Polonsky","orcid":"0000-0003-2112-9244","position":7,"is_corresponding":false},{"id":630125,"name":"Rajesh Gupta","orcid":"0000-0001-7428-7671","position":8,"is_corresponding":false},{"id":1221754,"name":"Caroline Alsweiler","orcid":"0009-0004-9463-0165","position":9,"is_corresponding":false},{"id":1026769,"name":"Johanne Silvain","orcid":"0000-0002-1901-2808","position":10,"is_corresponding":false},{"id":260559,"name":"Pedro Gabriel Melo de Barros e Silva","orcid":"0000-0003-1940-4470","position":11,"is_corresponding":false},{"id":845613,"name":"Graham S. Hillis","orcid":"0000-0003-2417-4673","position":12,"is_corresponding":false},{"id":1222395,"name":"Benoit Daneault","orcid":null,"position":13,"is_corresponding":false},{"id":1222396,"name":"Meechai Tessalee","orcid":null,"position":14,"is_corresponding":false},{"id":1222397,"name":"Mark Menegus","orcid":null,"position":15,"is_corresponding":false},{"id":302873,"name":"Sunil V. Rao","orcid":"0000-0003-2914-0894","position":16,"is_corresponding":false},{"id":55170,"name":"Renato D. Lópes","orcid":"0000-0003-2999-4961","position":17,"is_corresponding":false},{"id":1221755,"name":"Paul C. Hébert","orcid":"0000-0002-0440-8586","position":18,"is_corresponding":false},{"id":55144,"name":"John H. Alexander","orcid":"0000-0002-1444-2462","position":19,"is_corresponding":false},{"id":309260,"name":"Maria M. Brooks","orcid":"0000-0002-2030-7873","position":20,"is_corresponding":false},{"id":247083,"name":"Jeffrey L. Carson","orcid":"0000-0001-5466-2833","position":21,"is_corresponding":false},{"id":228983,"name":"Shaun G. Goodman","orcid":"0000-0001-8068-2440","position":22,"is_corresponding":false},{"id":1222398,"name":"for the MINT Investigators","orcid":null,"position":23,"is_corresponding":false},{"id":456720,"name":"Andrew P. DeFilippis","orcid":"0000-0002-5135-9748","position":0,"is_corresponding":true}],"reference_count":23,"raw_metadata":null,"created_at":"2026-07-19T01:58:21.523756Z","pmid":"39206549","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}